Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1992 Nov;68(805):932–934. doi: 10.1136/pgmj.68.805.932

Carnitine deficiency associated with long-term pivampicillin treatment: the effect of a replacement therapy regime.

S J Rose 1, T C Stokes 1, S Patel 1, M B Cooper 1, D J Betteridge 1, J E Payne 1
PMCID: PMC2399489  PMID: 1494519

Abstract

A 51 year old female developed a skeletal muscle myopathy after 3 months of pivampicillin therapy. Pivampicillin can cause carnitine deficiency due to the pivalic acid side group. Plasma carnitine content and the patients symptoms failed to improve significantly on discontinuing the drug. Oral carnitine replacement therapy was administered for 6 weeks but the patient's plasma carnitine levels responded only slowly to this treatment. It is suggested that pivampicillin inhibits uptake of carnitine from the gut and may either directly or indirectly depress endogenous carnitine synthesis. In such cases a more aggressive carnitine replacement regime is indicated and pivampicillin should be avoided in patients requiring long-term antibiotic administration.

Full text

PDF
932

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bremer J. Carnitine--metabolism and functions. Physiol Rev. 1983 Oct;63(4):1420–1480. doi: 10.1152/physrev.1983.63.4.1420. [DOI] [PubMed] [Google Scholar]
  2. Cederblad G., Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta. 1972 Mar;37:235–243. doi: 10.1016/0009-8981(72)90438-x. [DOI] [PubMed] [Google Scholar]
  3. Goa K. L., Brogden R. N. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs. 1987 Jul;34(1):1–24. doi: 10.2165/00003495-198734010-00001. [DOI] [PubMed] [Google Scholar]
  4. Greig C., Finch K. M., Jones D. A., Cooper M., Sargeant A. J., Forte C. A. The effect of oral supplementation with L-carnitine on maximum and submaximum exercise capacity. Eur J Appl Physiol Occup Physiol. 1987;56(4):457–460. doi: 10.1007/BF00417775. [DOI] [PubMed] [Google Scholar]
  5. Holme E., Greter J., Jacobson C. E., Lindstedt S., Nordin I., Kristiansson B., Jodal U. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989 Aug 26;2(8661):469–473. doi: 10.1016/s0140-6736(89)92086-2. [DOI] [PubMed] [Google Scholar]
  6. Melegh B., Kerner J., Bieber L. L. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol. 1987 Oct 15;36(20):3405–3409. doi: 10.1016/0006-2952(87)90318-2. [DOI] [PubMed] [Google Scholar]
  7. Zarrabi M. H., Rosner F. Rarity of failure of penicillin prophylaxis to prevent postsplenectomy sepsis. Arch Intern Med. 1986 Jun;146(6):1207–1208. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES